SKYSTAR BIO-PHARMACEUTICAL CO Stock-Based Compensation
SKYSTAR BIO-PHARMACEUTICAL CO reported Stock-Based Compensation of $209.52 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for the quarter ending 2014-09-30 was $54.29K.
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for the quarter ending 2014-06-30 was $95.50K, a 2100.58% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $59.73K, a 1276.15% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for the quarter ending 2013-12-31 was $140.32K, a 62.86% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for fiscal 2013 was $143.55K, a 66.60% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO share-based payment arrangement, noncash expense for fiscal 2012 was $86.16K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2014-09-30 | $54.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $149.80K derived: sum of 2 quarters · filed 2014-11-14 | $209.52K 10-Q · filed 2014-11-14 | $349.85K derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $95.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $155.23K 10-Q · filed 2014-08-14 | $295.55K derived: sum of 3 quarters · filed 2014-08-14 | $290.10K derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $59.73K 10-Q · filed 2014-05-15 | $200.05K derived: sum of 2 quarters · filed 2014-05-15 | $194.59K derived: sum of 3 quarters · filed 2014-11-14 | $198.93K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $140.32K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $134.87K derived: sum of 2 quarters · filed 2014-11-14 | $139.21K derived: sum of 3 quarters · filed 2014-11-14 | $143.55K 10-K · filed 2014-03-31 |
| 2013-09-30 | -$5.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.11K derived: sum of 2 quarters · filed 2014-11-14 | $3.23K 10-Q · filed 2014-11-14 | $89.39K derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $4.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $8.68K 10-Q · filed 2014-08-14 | $94.84K derived: sum of 3 quarters · filed 2014-08-14 | $94.84K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $4.34K 10-Q · filed 2014-05-15 | $90.50K derived: sum of 2 quarters · filed 2014-05-15 | $90.50K derived: sum of 3 quarters · filed 2014-05-15 | |
| 2012-12-31 | $86.16K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $86.16K derived: sum of 2 quarters · filed 2014-03-31 | $86.16K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-13 | |||
| 2011-09-30 | $46.44K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $72.97K 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $26.52K 10-Q/A · filed 2012-09-13 |